The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
复制标题
DOI:
10.1021/jm901134w
复制
发表时间:
2009-11-26
影响因子:
7.3
通讯作者:
Owens SM
中科院分区:
文献类型:
--
作者:
Carroll FI;Abraham P;Gong PK;Pidaparthi RR;Blough BE;Che Y;Hampton A;Gunnell M;Lay JO Jr;Peterson EC;Owens SM
In addition to addiction, the repeated use of (+)-methamphetamine [(+)-METH], (+)amphetamine [(+)-AMP], or (±)-methylenedioxymethamphetamine [(±)-MDMA, commonly called ecstasy] can lead to life-threatening medical problems including cardiovascular injury, severe depression, and psychosis. Currently, there are no specific pharmacotherapies to treat these medical problems. In this study, we report the design and synthesis of two haptens, (S)-(+)-3-(9-carboxynonyloxy)methamphetamine [3a, (+)-METHMO10] and (S)-(+)-3-(5-carboxypentyloxy)methamphetamine [3b, (+)-METH MO6], and their use in generating high affinity (low KD value) monoclonal antibodies (mAbs) against (+)-METH, (+)-AMP, and/or (+)-MDMA. Based on results from the determination of mAb KD values and ligand specificity, the mAbs generated from hapten 3a showed the greatest promise for generating active and passive immunotherapies for treating overdose or addiction from (+)-METH-like stimulants.
登录
查看更多内容
DOI:
10.4161/hv.5.4.7456
发表时间:
2009-04
期刊:
Human vaccines
影响因子:
--
作者:
Gentry WB;Rüedi-Bettschen D;Owens SM
通讯作者:
Owens SM
影响因子:
56.9
作者:
CHO, AK
通讯作者:
CHO, AK
影响因子:
2.9
作者:
DAVIS, MTB;PRESTON, JF
通讯作者:
PRESTON, JF
DOI:
10.1124/jpet.106.117150
发表时间:
2007-07-01
影响因子:
3.5
作者:
Peterson, Eric C.;Gunnell, Melinda;Owens, S. Michael
通讯作者:
Owens, S. Michael
影响因子:
2.7
作者:
Murray, JB
通讯作者:
Murray, JB